Intravenous Furosemide Dosing
For acute decompensated heart failure, start with 40 mg IV furosemide given slowly over 1-2 minutes if the patient has acute pulmonary edema or is not on chronic diuretics; if already on chronic oral diuretics, give at least the equivalent of their home oral dose (typically 40-80 mg IV) as the initial dose. 1, 2
Initial Dosing Strategy
The approach depends on the patient's diuretic history:
For Diuretic-Naive Patients or New-Onset Heart Failure
- Start with 20-40 mg IV furosemide 1
- For acute pulmonary edema specifically: 40 mg IV is the standard initial dose 2
- Administer slowly over 1-2 minutes to minimize ototoxicity risk 2
For Patients Already on Chronic Oral Diuretics
- Initial IV dose should equal or exceed their home oral dose 1
- Example: If taking 40 mg oral daily, give at least 40 mg IV initially
- The 2016 ESC guidelines explicitly state the IV dose should be "at least equivalent to oral dose" 1
Dose Escalation Protocol
If inadequate response after initial dose:
- Wait 2 hours, then increase by 20 mg increments 2
- For acute pulmonary edema with insufficient response at 1 hour: increase to 80 mg IV 2
- Maximum single bolus dose: 160-200 mg 3
Continuous Infusion vs. Bolus Dosing
Either method is acceptable—choose based on institutional preference and monitoring capability. The landmark DOSE trial found no significant difference in symptom relief or renal function between bolus every 12 hours versus continuous infusion 4. However:
- Bolus dosing: Give every 12 hours, easier to administer
- Continuous infusion: Load with 40 mg IV, then infuse at 10-40 mg/hour 3
- Maximum infusion rate: 4 mg/min to reduce ototoxicity risk 2
High-Dose vs. Low-Dose Strategy
Consider starting with a high-dose strategy (2.5 times the home oral dose) in patients with significant congestion or known diuretic resistance. The DOSE trial showed a trend toward better symptom improvement with high-dose therapy (though not statistically significant, p=0.06), with greater diuresis and more favorable secondary outcomes 4. The trade-off is transient worsening of renal function, which typically resolves.
Critical Safety Considerations
Administration Speed
- Always give slowly over 1-2 minutes 2
- For high-dose therapy, use controlled infusion at ≤4 mg/min 2
- Rapid injection increases ototoxicity risk, especially with renal impairment 2
Monitoring Requirements
- Check electrolytes (potassium, magnesium) and renal function regularly 1
- Monitor urine output, symptoms, and blood pressure 1
- Watch for hypokalemia, which predisposes to arrhythmias, particularly with concurrent digoxin 3
pH Compatibility
- Furosemide is alkaline (pH ~9) and precipitates in acidic solutions 2
- Never mix with acidic drugs (labetalol, ciprofloxacin, amrinone, milrinone) in the same IV line 2
- If preparing infusion, ensure pH >5.5 using compatible solutions (NS, LR, D5W) 2
Common Pitfalls to Avoid
- Underdosing chronic diuretic users: Patients on home diuretics need higher initial doses due to tolerance—don't start with 20 mg if they take 80 mg oral daily
- Rapid IV push: Increases ototoxicity and hearing loss risk 2
- Ignoring electrolytes: Hypokalemia and hypomagnesemia are common and dangerous, especially with combination diuretic therapy 3
- Excessive diuresis: Can cause hypotension, azotemia, and impaired exercise tolerance—if these occur without congestion signs, reduce the dose 3
Special Populations
Hepatic Cirrhosis with Ascites
- Initiate therapy in hospital setting only 2
- Add aldosterone antagonist and potassium supplementation 2
- Strict monitoring required—sudden fluid shifts can precipitate hepatic coma 2